Fentanyl Patch, Extended Release
Product Images NDC 50742-552

Product Visual Gallery

This gallery contains 21 technical images submitted to the FDA as part of the official labeling for Fentanyl (NDC 50742-552). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ingenus Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton 100 Mcg (Carton 100 Mcg)

Packaging label for Fentanyl Transdermal System 100 mcg/h patch by Ingenus Pharmaceuticals, LLC. The label highlights the extended-release transdermal delivery of 100 mcg/h fentanyl, includes safety warnings, barcode, and usage instructions. It identifies the product as a prescription drug with the NDC 50742-556-05.*

FDA Label Image

Carton 12 Mcg (Carton 12 Mcg)

Fentanyl Transdermal System 12 mcg/h extended-release patch packaging from Ingenuus Pharmaceuticals, LLC. The carton includes warnings about respiratory risks and instructions to keep out of reach of children. The label specifies in vivo delivery of 12 mcg/h fentanyl for 72 hours and contains 1.38 mg fentanyl per patch. It bears a barcode and usage caution highlighting opioid pain medication.*

FDA Label Image

Carton 25 Mcg (Carton 25 Mcg)

Fentanyl Transdermal System 25 mcg/h extended-release patch packaging carton from Ingenus Pharmaceuticals, LLC. The label displays warnings about the risk of fatal breathing trouble, usage restrictions, and instructions to keep out of reach of children. It specifies in vivo delivery of 25 mcg/h fentanyl for 72 hours, with each system containing 2.76 mg fentanyl. The carton includes barcodes and manufacturer information for Aveva Drug Delivery Systems.*

FDA Label Image

Carton 37.5 Mcg (Carton 37 5 Mcg)

Packaging label for Fentanyl Transdermal System 37.5 mcg/h, an extended-release patch for transdermal use. The label states it is manufactured by Ingenus Pharmaceuticals, LLC and includes warnings about risks associated with use. It provides dosing information and instructions to keep out of reach of children. A barcode, manufacturer details, and dosage specifications are also visible on the packaging.*

FDA Label Image

Carton 50 Mcg (Carton 50 Mcg)

Box packaging for Fentanyl Transdermal System 50 mcg/h patch by Ingenus Pharmaceuticals, LLC. The label highlights the product name, dosage strength of 50 micrograms per hour, and mentions it is an extended release transdermal patch. Warning information about use precautions and safety instructions are visible, along with manufacturer details and barcodes on the box panels.*

FDA Label Image

Carton 62.5 Mcg (Carton 62 5 Mcg)

The image shows a packaging label for Fentanyl Transdermal System, 62.5 mcg/h strength, an extended-release transdermal patch by Ingenus Pharmaceuticals, LLC. The label includes usage warnings, dosage strength, and manufacturer information. It also displays the NDC number 50742-553-05 and notes that the patch delivers fentanyl for 72 hours with a content of 6.90 mg per system.*

FDA Label Image

Carton 75 Mcg (Carton 75 Mcg)

The image shows a carton label for Fentanyl Transdermal System 75 mcg/h by Ingenus Pharmaceuticals, LLC. It is an extended-release transdermal patch delivering 75 micrograms per hour of fentanyl. The label includes warnings, dosage information, and a barcode, indicating it is for prescription use only.*

FDA Label Image

Carton 87.5 Mcg (Carton 87 5 Mcg)

Fentanyl Transdermal System patch labeled with 87.5 mcg/h strength. The packaging is for a box containing five patches and includes safety warnings about breath trouble and opioid use. It is a prescription-only product by Ingenus Pharmaceuticals, LLC, with NDC 50742-555-05. The label features barcodes, a red warning symbol, and the dose strength in a purple bar on the front and side panels.*

FDA Label Image

Figure A To D (Figure A D)

Instructional diagrams showing recommended application sites for FENTANYL transdermal patches. Figures depict patch placement on the chest below the clavicle (Figure A and B), the side of the upper arm (Figure C), and the side of the chest below the armpit (Figure D). The illustrations emphasize external skin locations suitable for patch adherence.*

FDA Label Image

Figure E (Figure E)

An instructional anatomical illustration labeled "Figure E" showing a person scratching their right chest area with their right hand. The image is part of user guidance likely related to the use or effect of a Fentanyl transdermal patch.*

FDA Label Image

Figure F (Figure F)

An instructional illustration labeled 'Figure F' showing a pair of hands cutting a rectangular patch with scissors, likely demonstrating how to cut a fentanyl transdermal patch for dosing or application purposes.*

FDA Label Image

Figure G (Figure G)

An instructional illustration showing two hands holding and preparing to apply a rectangular transdermal patch with a black center area, labeled as Figure G. It likely demonstrates the correct way to handle the FENTANYL extended-release transdermal patch.*

FDA Label Image

Figure H (Figure H)

An illustration showing the correct placement of a transdermal patch on the upper chest near the shoulder, depicting a person with one hand placing the patch on the skin.*

FDA Label Image

Figure I To J (Figure I J)

Illustrations labeled Figure I and Figure J showing hands manipulating the product. Figure I depicts fingers pulling apart a backing or seal. Figure J shows a hand placing the product onto a round container or surface, likely demonstrating application or removal steps for the FENTANYL transdermal patch.*

FDA Label Image

Figure 1 (Figure1)

A line graph showing fentanyl concentration (ng/mL) over time (hours) for Fentanyl Transdermal System 100 mcg/hr with single and multiple dosing. The graph displays mean concentration values with error bars across time points up to approximately 340 hours.*

FDA Label Image

Logo (Logo)

FDA Label Image

Logo (Logo1)

FDA Label Image

Logo (Logo2)

FDA Label Image

Patch (Patch)

An illustration diagram of a transdermal FENTANYL patch showing the three labeled layers: Release Liner, Drug Containing Layer, and Backing Layer. The diagram displays the patch with one corner of the release liner partially peeled back to reveal the drug containing layer beneath.*

FDA Label Image

Patch (Patch2)

An illustration diagram of a fentanyl transdermal patch showing its three main layers: the release liner, drug containing layer, and backing layer. The diagram visually represents the layered structure of the extended release patch used for transdermal delivery.*

FDA Label Image

Structure (Structure)

Chemical structure of fentanyl, depicting its molecular framework with characteristic rings and side chains, representing the active ingredient of the FENTANYL transdermal patch by Ingenus Pharmaceuticals LLC.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.